Abstract | PURPOSE OF REVIEW: It is difficult to identify specific groups of asthmatic patients who may benefit from acute or chronic use of anticholinergic agents. Therefore, an important consideration is how anticholinergic agents can be used to achieve clinically effective treatment of asthma. RECENT FINDINGS: SUMMARY:
|
Authors | Hiroshi Kanazawa |
Journal | Current opinion in pulmonary medicine
(Curr Opin Pulm Med)
Vol. 12
Issue 1
Pg. 60-7
(Jan 2006)
ISSN: 1070-5287 [Print] United States |
PMID | 16357581
(Publication Type: Journal Article, Review)
|
Chemical References |
- Adrenergic beta-Agonists
- Anti-Asthmatic Agents
- Bronchodilator Agents
- Cholinergic Antagonists
- Receptors, Muscarinic
|
Topics |
- Adrenergic beta-Agonists
(therapeutic use)
- Airway Resistance
(drug effects)
- Animals
- Anti-Asthmatic Agents
(therapeutic use)
- Asthma
(drug therapy)
- Bronchodilator Agents
(therapeutic use)
- Child
- Cholinergic Antagonists
(therapeutic use)
- Drug Therapy, Combination
- Humans
- Inflammation
(drug therapy, virology)
- Muscle, Smooth
(drug effects)
- Randomized Controlled Trials as Topic
- Receptors, Muscarinic
(classification, physiology)
|